ClinicalTrials.Veeva

Menu

Ascending Aortic Dilation in BiAV After TAVR

Seoul National University logo

Seoul National University

Status

Unknown

Conditions

Aortic Valve Stenosis

Treatments

Other: diagnosed as bicuspid aortic valve

Study type

Observational

Funder types

Other

Identifiers

NCT03051334
1701-104-825

Details and patient eligibility

About

This study sought to evaluate changes in ascending aorta size after transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic valve (BiAV) compared with patients with tricuspid aortic valve (TAV).

Full description

The growth rate of ascending aorta was calculated as annual growth rate using baseline and the last echocardiography. The difference in ascending aorta growth rates between the two groups (BiAV and TAV) were analyzed by independent t-test.

Enrollment

100 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Severe AS who underwent TAVR

Exclusion criteria

  • ascending aorta more than 50mm

Trial design

100 participants in 2 patient groups

BiAV
Description:
Bicuspid aortic valve
Treatment:
Other: diagnosed as bicuspid aortic valve
TAV
Description:
Tricuspid aortic valve

Trial contacts and locations

1

Loading...

Central trial contact

Ji-Hyun Jung, MD; Hyung-Kwan Kim, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems